nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—osteoarthritis—Methylprednisolone—multiple sclerosis	0.272	0.5	CpDpCtD
Etodolac—osteoarthritis—Prednisone—multiple sclerosis	0.272	0.5	CpDpCtD
Etodolac—ALB—multiple sclerosis	0.157	1	CbGaD
Etodolac—PTGS2—Triamcinolone—multiple sclerosis	0.0438	0.279	CbGbCtD
Etodolac—PTGS2—Betamethasone—multiple sclerosis	0.0376	0.24	CbGbCtD
Etodolac—ALB—Prednisone—multiple sclerosis	0.0221	0.141	CbGbCtD
Etodolac—PTGS2—Dexamethasone—multiple sclerosis	0.0219	0.139	CbGbCtD
Etodolac—SLC22A6—Methotrexate—multiple sclerosis	0.013	0.0829	CbGbCtD
Etodolac—ALB—Methotrexate—multiple sclerosis	0.0111	0.0706	CbGbCtD
Etodolac—CYP2C9—Dexamethasone—multiple sclerosis	0.00744	0.0474	CbGbCtD
Etodolac—PTGS2—Fluocinonide—Methylprednisolone—multiple sclerosis	0.00038	0.159	CbGdCrCtD
Etodolac—PTGS2—Fluocinonide—Dexamethasone—multiple sclerosis	0.000374	0.156	CbGdCrCtD
Etodolac—PTGS2—Fluocinonide—Betamethasone—multiple sclerosis	0.000374	0.156	CbGdCrCtD
Etodolac—PTGS2—Fluocinonide—Triamcinolone—multiple sclerosis	0.000365	0.153	CbGdCrCtD
Etodolac—PTGS2—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.000229	0.0958	CbGdCrCtD
Etodolac—PTGS2—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.000225	0.0943	CbGdCrCtD
Etodolac—PTGS2—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.000225	0.0943	CbGdCrCtD
Etodolac—PTGS2—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.00022	0.0921	CbGdCrCtD
Etodolac—Stomatitis—Methotrexate—multiple sclerosis	9.04e-05	0.000894	CcSEcCtD
Etodolac—Conjunctivitis—Methotrexate—multiple sclerosis	9.02e-05	0.000891	CcSEcCtD
Etodolac—Confusional state—Methylprednisolone—multiple sclerosis	9.02e-05	0.000891	CcSEcCtD
Etodolac—Malaise—Dexamethasone—multiple sclerosis	8.98e-05	0.000888	CcSEcCtD
Etodolac—Malaise—Betamethasone—multiple sclerosis	8.98e-05	0.000888	CcSEcCtD
Etodolac—Oedema—Triamcinolone—multiple sclerosis	8.96e-05	0.000885	CcSEcCtD
Etodolac—Anaphylactic shock—Triamcinolone—multiple sclerosis	8.96e-05	0.000885	CcSEcCtD
Etodolac—Vertigo—Dexamethasone—multiple sclerosis	8.95e-05	0.000884	CcSEcCtD
Etodolac—Vertigo—Betamethasone—multiple sclerosis	8.95e-05	0.000884	CcSEcCtD
Etodolac—Anaphylactic shock—Methylprednisolone—multiple sclerosis	8.94e-05	0.000883	CcSEcCtD
Etodolac—Syncope—Dexamethasone—multiple sclerosis	8.93e-05	0.000883	CcSEcCtD
Etodolac—Syncope—Betamethasone—multiple sclerosis	8.93e-05	0.000883	CcSEcCtD
Etodolac—Arrhythmia—Prednisone—multiple sclerosis	8.9e-05	0.00088	CcSEcCtD
Etodolac—Infection—Triamcinolone—multiple sclerosis	8.9e-05	0.00088	CcSEcCtD
Etodolac—Sweating—Methotrexate—multiple sclerosis	8.9e-05	0.000879	CcSEcCtD
Etodolac—Infection—Methylprednisolone—multiple sclerosis	8.88e-05	0.000878	CcSEcCtD
Etodolac—Haematuria—Methotrexate—multiple sclerosis	8.85e-05	0.000874	CcSEcCtD
Etodolac—Shock—Triamcinolone—multiple sclerosis	8.82e-05	0.000871	CcSEcCtD
Etodolac—Insomnia—Prednisolone—multiple sclerosis	8.81e-05	0.000871	CcSEcCtD
Etodolac—Alopecia—Prednisone—multiple sclerosis	8.81e-05	0.00087	CcSEcCtD
Etodolac—Shock—Methylprednisolone—multiple sclerosis	8.8e-05	0.000869	CcSEcCtD
Etodolac—Loss of consciousness—Dexamethasone—multiple sclerosis	8.76e-05	0.000865	CcSEcCtD
Etodolac—Loss of consciousness—Betamethasone—multiple sclerosis	8.76e-05	0.000865	CcSEcCtD
Etodolac—Hypersensitivity—Mitoxantrone—multiple sclerosis	8.75e-05	0.000865	CcSEcCtD
Etodolac—Paraesthesia—Prednisolone—multiple sclerosis	8.75e-05	0.000864	CcSEcCtD
Etodolac—Tachycardia—Triamcinolone—multiple sclerosis	8.75e-05	0.000864	CcSEcCtD
Etodolac—Nausea—Azathioprine—multiple sclerosis	8.73e-05	0.000862	CcSEcCtD
Etodolac—Tachycardia—Methylprednisolone—multiple sclerosis	8.73e-05	0.000862	CcSEcCtD
Etodolac—Hyperhidrosis—Triamcinolone—multiple sclerosis	8.66e-05	0.000856	CcSEcCtD
Etodolac—Agranulocytosis—Methotrexate—multiple sclerosis	8.66e-05	0.000855	CcSEcCtD
Etodolac—Hyperhidrosis—Methylprednisolone—multiple sclerosis	8.64e-05	0.000854	CcSEcCtD
Etodolac—Convulsion—Betamethasone—multiple sclerosis	8.63e-05	0.000853	CcSEcCtD
Etodolac—Convulsion—Dexamethasone—multiple sclerosis	8.63e-05	0.000853	CcSEcCtD
Etodolac—Hypertension—Dexamethasone—multiple sclerosis	8.6e-05	0.00085	CcSEcCtD
Etodolac—Hypertension—Betamethasone—multiple sclerosis	8.6e-05	0.00085	CcSEcCtD
Etodolac—Asthenia—Mitoxantrone—multiple sclerosis	8.52e-05	0.000842	CcSEcCtD
Etodolac—Myalgia—Betamethasone—multiple sclerosis	8.48e-05	0.000838	CcSEcCtD
Etodolac—Myalgia—Dexamethasone—multiple sclerosis	8.48e-05	0.000838	CcSEcCtD
Etodolac—Anxiety—Betamethasone—multiple sclerosis	8.45e-05	0.000835	CcSEcCtD
Etodolac—Anxiety—Dexamethasone—multiple sclerosis	8.45e-05	0.000835	CcSEcCtD
Etodolac—Discomfort—Dexamethasone—multiple sclerosis	8.38e-05	0.000828	CcSEcCtD
Etodolac—Discomfort—Betamethasone—multiple sclerosis	8.38e-05	0.000828	CcSEcCtD
Etodolac—Haemoglobin—Methotrexate—multiple sclerosis	8.37e-05	0.000827	CcSEcCtD
Etodolac—Hypotension—Methylprednisolone—multiple sclerosis	8.36e-05	0.000825	CcSEcCtD
Etodolac—Pain—Prednisolone—multiple sclerosis	8.33e-05	0.000823	CcSEcCtD
Etodolac—Haemorrhage—Methotrexate—multiple sclerosis	8.33e-05	0.000823	CcSEcCtD
Etodolac—Hepatitis—Methotrexate—multiple sclerosis	8.33e-05	0.000823	CcSEcCtD
Etodolac—Pharyngitis—Methotrexate—multiple sclerosis	8.27e-05	0.000817	CcSEcCtD
Etodolac—Vision blurred—Prednisone—multiple sclerosis	8.18e-05	0.000808	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	8.16e-05	0.000807	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	8.15e-05	0.000805	CcSEcCtD
Etodolac—Anaphylactic shock—Dexamethasone—multiple sclerosis	8.13e-05	0.000803	CcSEcCtD
Etodolac—Anaphylactic shock—Betamethasone—multiple sclerosis	8.13e-05	0.000803	CcSEcCtD
Etodolac—Oedema—Betamethasone—multiple sclerosis	8.13e-05	0.000803	CcSEcCtD
Etodolac—Oedema—Dexamethasone—multiple sclerosis	8.13e-05	0.000803	CcSEcCtD
Etodolac—Diarrhoea—Mitoxantrone—multiple sclerosis	8.13e-05	0.000803	CcSEcCtD
Etodolac—Insomnia—Triamcinolone—multiple sclerosis	8.11e-05	0.000801	CcSEcCtD
Etodolac—Insomnia—Methylprednisolone—multiple sclerosis	8.09e-05	0.000799	CcSEcCtD
Etodolac—Infection—Dexamethasone—multiple sclerosis	8.08e-05	0.000798	CcSEcCtD
Etodolac—Infection—Betamethasone—multiple sclerosis	8.08e-05	0.000798	CcSEcCtD
Etodolac—Ill-defined disorder—Prednisone—multiple sclerosis	8.05e-05	0.000795	CcSEcCtD
Etodolac—Paraesthesia—Triamcinolone—multiple sclerosis	8.05e-05	0.000795	CcSEcCtD
Etodolac—Feeling abnormal—Prednisolone—multiple sclerosis	8.03e-05	0.000793	CcSEcCtD
Etodolac—Paraesthesia—Methylprednisolone—multiple sclerosis	8.03e-05	0.000793	CcSEcCtD
Etodolac—Visual impairment—Methotrexate—multiple sclerosis	8.03e-05	0.000793	CcSEcCtD
Etodolac—Anaemia—Prednisone—multiple sclerosis	8.02e-05	0.000792	CcSEcCtD
Etodolac—Shock—Dexamethasone—multiple sclerosis	8e-05	0.00079	CcSEcCtD
Etodolac—Shock—Betamethasone—multiple sclerosis	8e-05	0.00079	CcSEcCtD
Etodolac—Dyspnoea—Triamcinolone—multiple sclerosis	7.99e-05	0.000789	CcSEcCtD
Etodolac—Thrombocytopenia—Dexamethasone—multiple sclerosis	7.96e-05	0.000787	CcSEcCtD
Etodolac—Thrombocytopenia—Betamethasone—multiple sclerosis	7.96e-05	0.000787	CcSEcCtD
Etodolac—Tachycardia—Betamethasone—multiple sclerosis	7.94e-05	0.000784	CcSEcCtD
Etodolac—Tachycardia—Dexamethasone—multiple sclerosis	7.94e-05	0.000784	CcSEcCtD
Etodolac—Angioedema—Prednisone—multiple sclerosis	7.93e-05	0.000783	CcSEcCtD
Etodolac—Dyspepsia—Triamcinolone—multiple sclerosis	7.89e-05	0.000779	CcSEcCtD
Etodolac—Erythema multiforme—Methotrexate—multiple sclerosis	7.88e-05	0.000778	CcSEcCtD
Etodolac—Dyspepsia—Methylprednisolone—multiple sclerosis	7.87e-05	0.000778	CcSEcCtD
Etodolac—Hyperhidrosis—Betamethasone—multiple sclerosis	7.86e-05	0.000777	CcSEcCtD
Etodolac—Hyperhidrosis—Dexamethasone—multiple sclerosis	7.86e-05	0.000777	CcSEcCtD
Etodolac—Malaise—Prednisone—multiple sclerosis	7.82e-05	0.000773	CcSEcCtD
Etodolac—Vertigo—Prednisone—multiple sclerosis	7.8e-05	0.00077	CcSEcCtD
Etodolac—Syncope—Prednisone—multiple sclerosis	7.78e-05	0.000769	CcSEcCtD
Etodolac—Tinnitus—Methotrexate—multiple sclerosis	7.77e-05	0.000767	CcSEcCtD
Etodolac—Anorexia—Dexamethasone—multiple sclerosis	7.75e-05	0.000766	CcSEcCtD
Etodolac—Anorexia—Betamethasone—multiple sclerosis	7.75e-05	0.000766	CcSEcCtD
Etodolac—Urticaria—Prednisolone—multiple sclerosis	7.74e-05	0.000765	CcSEcCtD
Etodolac—Fatigue—Triamcinolone—multiple sclerosis	7.73e-05	0.000763	CcSEcCtD
Etodolac—Fatigue—Methylprednisolone—multiple sclerosis	7.71e-05	0.000762	CcSEcCtD
Etodolac—Pain—Triamcinolone—multiple sclerosis	7.66e-05	0.000757	CcSEcCtD
Etodolac—Loss of consciousness—Prednisone—multiple sclerosis	7.63e-05	0.000753	CcSEcCtD
Etodolac—Hypotension—Betamethasone—multiple sclerosis	7.6e-05	0.000751	CcSEcCtD
Etodolac—Hypotension—Dexamethasone—multiple sclerosis	7.6e-05	0.000751	CcSEcCtD
Etodolac—Vomiting—Mitoxantrone—multiple sclerosis	7.55e-05	0.000746	CcSEcCtD
Etodolac—Convulsion—Prednisone—multiple sclerosis	7.52e-05	0.000743	CcSEcCtD
Etodolac—Hypertension—Prednisone—multiple sclerosis	7.49e-05	0.00074	CcSEcCtD
Etodolac—Rash—Mitoxantrone—multiple sclerosis	7.49e-05	0.00074	CcSEcCtD
Etodolac—Dermatitis—Mitoxantrone—multiple sclerosis	7.48e-05	0.000739	CcSEcCtD
Etodolac—Chills—Methotrexate—multiple sclerosis	7.47e-05	0.000738	CcSEcCtD
Etodolac—Headache—Mitoxantrone—multiple sclerosis	7.44e-05	0.000735	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	7.41e-05	0.000732	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	7.41e-05	0.000732	CcSEcCtD
Etodolac—Arthralgia—Prednisone—multiple sclerosis	7.39e-05	0.00073	CcSEcCtD
Etodolac—Myalgia—Prednisone—multiple sclerosis	7.39e-05	0.00073	CcSEcCtD
Etodolac—Feeling abnormal—Triamcinolone—multiple sclerosis	7.38e-05	0.00073	CcSEcCtD
Etodolac—Feeling abnormal—Methylprednisolone—multiple sclerosis	7.37e-05	0.000728	CcSEcCtD
Etodolac—Anxiety—Prednisone—multiple sclerosis	7.36e-05	0.000727	CcSEcCtD
Etodolac—Alopecia—Methotrexate—multiple sclerosis	7.36e-05	0.000727	CcSEcCtD
Etodolac—Insomnia—Dexamethasone—multiple sclerosis	7.35e-05	0.000727	CcSEcCtD
Etodolac—Insomnia—Betamethasone—multiple sclerosis	7.35e-05	0.000727	CcSEcCtD
Etodolac—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	7.31e-05	0.000722	CcSEcCtD
Etodolac—Paraesthesia—Dexamethasone—multiple sclerosis	7.3e-05	0.000721	CcSEcCtD
Etodolac—Paraesthesia—Betamethasone—multiple sclerosis	7.3e-05	0.000721	CcSEcCtD
Etodolac—Discomfort—Prednisone—multiple sclerosis	7.3e-05	0.000721	CcSEcCtD
Etodolac—Hypersensitivity—Prednisolone—multiple sclerosis	7.18e-05	0.000709	CcSEcCtD
Etodolac—Dyspepsia—Dexamethasone—multiple sclerosis	7.16e-05	0.000707	CcSEcCtD
Etodolac—Dyspepsia—Betamethasone—multiple sclerosis	7.16e-05	0.000707	CcSEcCtD
Etodolac—Urticaria—Triamcinolone—multiple sclerosis	7.12e-05	0.000703	CcSEcCtD
Etodolac—Urticaria—Methylprednisolone—multiple sclerosis	7.1e-05	0.000702	CcSEcCtD
Etodolac—Dysgeusia—Methotrexate—multiple sclerosis	7.1e-05	0.000702	CcSEcCtD
Etodolac—Body temperature increased—Triamcinolone—multiple sclerosis	7.08e-05	0.0007	CcSEcCtD
Etodolac—Anaphylactic shock—Prednisone—multiple sclerosis	7.08e-05	0.0007	CcSEcCtD
Etodolac—Oedema—Prednisone—multiple sclerosis	7.08e-05	0.0007	CcSEcCtD
Etodolac—Abdominal pain—Methylprednisolone—multiple sclerosis	7.07e-05	0.000698	CcSEcCtD
Etodolac—Decreased appetite—Dexamethasone—multiple sclerosis	7.07e-05	0.000698	CcSEcCtD
Etodolac—Decreased appetite—Betamethasone—multiple sclerosis	7.07e-05	0.000698	CcSEcCtD
Etodolac—Nausea—Mitoxantrone—multiple sclerosis	7.06e-05	0.000697	CcSEcCtD
Etodolac—Infection—Prednisone—multiple sclerosis	7.04e-05	0.000695	CcSEcCtD
Etodolac—Fatigue—Dexamethasone—multiple sclerosis	7.01e-05	0.000693	CcSEcCtD
Etodolac—Fatigue—Betamethasone—multiple sclerosis	7.01e-05	0.000693	CcSEcCtD
Etodolac—Shock—Prednisone—multiple sclerosis	6.97e-05	0.000688	CcSEcCtD
Etodolac—Pain—Dexamethasone—multiple sclerosis	6.95e-05	0.000687	CcSEcCtD
Etodolac—Pain—Betamethasone—multiple sclerosis	6.95e-05	0.000687	CcSEcCtD
Etodolac—Tachycardia—Prednisone—multiple sclerosis	6.91e-05	0.000683	CcSEcCtD
Etodolac—Hyperhidrosis—Prednisone—multiple sclerosis	6.85e-05	0.000676	CcSEcCtD
Etodolac—Vision blurred—Methotrexate—multiple sclerosis	6.83e-05	0.000675	CcSEcCtD
Etodolac—Anorexia—Prednisone—multiple sclerosis	6.75e-05	0.000667	CcSEcCtD
Etodolac—Ill-defined disorder—Methotrexate—multiple sclerosis	6.73e-05	0.000665	CcSEcCtD
Etodolac—Anaemia—Methotrexate—multiple sclerosis	6.7e-05	0.000662	CcSEcCtD
Etodolac—Feeling abnormal—Dexamethasone—multiple sclerosis	6.7e-05	0.000662	CcSEcCtD
Etodolac—Feeling abnormal—Betamethasone—multiple sclerosis	6.7e-05	0.000662	CcSEcCtD
Etodolac—Gastrointestinal pain—Betamethasone—multiple sclerosis	6.65e-05	0.000657	CcSEcCtD
Etodolac—Gastrointestinal pain—Dexamethasone—multiple sclerosis	6.65e-05	0.000657	CcSEcCtD
Etodolac—Hypersensitivity—Triamcinolone—multiple sclerosis	6.6e-05	0.000652	CcSEcCtD
Etodolac—Hypersensitivity—Methylprednisolone—multiple sclerosis	6.59e-05	0.000651	CcSEcCtD
Etodolac—Malaise—Methotrexate—multiple sclerosis	6.54e-05	0.000646	CcSEcCtD
Etodolac—Vertigo—Methotrexate—multiple sclerosis	6.51e-05	0.000644	CcSEcCtD
Etodolac—Leukopenia—Methotrexate—multiple sclerosis	6.49e-05	0.000641	CcSEcCtD
Etodolac—Urticaria—Betamethasone—multiple sclerosis	6.46e-05	0.000638	CcSEcCtD
Etodolac—Urticaria—Dexamethasone—multiple sclerosis	6.46e-05	0.000638	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Prednisone—multiple sclerosis	6.45e-05	0.000637	CcSEcCtD
Etodolac—Dizziness—Prednisolone—multiple sclerosis	6.44e-05	0.000637	CcSEcCtD
Etodolac—Asthenia—Triamcinolone—multiple sclerosis	6.43e-05	0.000635	CcSEcCtD
Etodolac—Body temperature increased—Betamethasone—multiple sclerosis	6.43e-05	0.000635	CcSEcCtD
Etodolac—Abdominal pain—Dexamethasone—multiple sclerosis	6.43e-05	0.000635	CcSEcCtD
Etodolac—Body temperature increased—Dexamethasone—multiple sclerosis	6.43e-05	0.000635	CcSEcCtD
Etodolac—Abdominal pain—Betamethasone—multiple sclerosis	6.43e-05	0.000635	CcSEcCtD
Etodolac—Asthenia—Methylprednisolone—multiple sclerosis	6.42e-05	0.000634	CcSEcCtD
Etodolac—Insomnia—Prednisone—multiple sclerosis	6.4e-05	0.000633	CcSEcCtD
Etodolac—Paraesthesia—Prednisone—multiple sclerosis	6.36e-05	0.000628	CcSEcCtD
Etodolac—Pruritus—Triamcinolone—multiple sclerosis	6.34e-05	0.000626	CcSEcCtD
Etodolac—Pruritus—Methylprednisolone—multiple sclerosis	6.33e-05	0.000625	CcSEcCtD
Etodolac—Convulsion—Methotrexate—multiple sclerosis	6.28e-05	0.000621	CcSEcCtD
Etodolac—Dyspepsia—Prednisone—multiple sclerosis	6.23e-05	0.000616	CcSEcCtD
Etodolac—Myalgia—Methotrexate—multiple sclerosis	6.17e-05	0.00061	CcSEcCtD
Etodolac—Arthralgia—Methotrexate—multiple sclerosis	6.17e-05	0.00061	CcSEcCtD
Etodolac—Decreased appetite—Prednisone—multiple sclerosis	6.16e-05	0.000608	CcSEcCtD
Etodolac—Rash—Prednisolone—multiple sclerosis	6.14e-05	0.000607	CcSEcCtD
Etodolac—Dermatitis—Prednisolone—multiple sclerosis	6.14e-05	0.000606	CcSEcCtD
Etodolac—Diarrhoea—Methylprednisolone—multiple sclerosis	6.12e-05	0.000604	CcSEcCtD
Etodolac—Fatigue—Prednisone—multiple sclerosis	6.11e-05	0.000603	CcSEcCtD
Etodolac—Headache—Prednisolone—multiple sclerosis	6.1e-05	0.000603	CcSEcCtD
Etodolac—Discomfort—Methotrexate—multiple sclerosis	6.1e-05	0.000603	CcSEcCtD
Etodolac—Constipation—Prednisone—multiple sclerosis	6.06e-05	0.000598	CcSEcCtD
Etodolac—PTGS2—Spinal Cord Injury—CXCL10—multiple sclerosis	6.05e-05	0.00163	CbGpPWpGaD
Etodolac—Confusional state—Methotrexate—multiple sclerosis	5.97e-05	0.00059	CcSEcCtD
Etodolac—Dizziness—Triamcinolone—multiple sclerosis	5.93e-05	0.000585	CcSEcCtD
Etodolac—Anaphylactic shock—Methotrexate—multiple sclerosis	5.92e-05	0.000585	CcSEcCtD
Etodolac—Dizziness—Methylprednisolone—multiple sclerosis	5.91e-05	0.000584	CcSEcCtD
Etodolac—Infection—Methotrexate—multiple sclerosis	5.88e-05	0.000581	CcSEcCtD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.84e-05	0.00157	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.84e-05	0.00157	CbGpPWpGaD
Etodolac—Feeling abnormal—Prednisone—multiple sclerosis	5.84e-05	0.000576	CcSEcCtD
Etodolac—Asthenia—Dexamethasone—multiple sclerosis	5.83e-05	0.000576	CcSEcCtD
Etodolac—Asthenia—Betamethasone—multiple sclerosis	5.83e-05	0.000576	CcSEcCtD
Etodolac—Thrombocytopenia—Methotrexate—multiple sclerosis	5.79e-05	0.000572	CcSEcCtD
Etodolac—Gastrointestinal pain—Prednisone—multiple sclerosis	5.79e-05	0.000572	CcSEcCtD
Etodolac—Nausea—Prednisolone—multiple sclerosis	5.79e-05	0.000572	CcSEcCtD
Etodolac—Pruritus—Betamethasone—multiple sclerosis	5.75e-05	0.000568	CcSEcCtD
Etodolac—Pruritus—Dexamethasone—multiple sclerosis	5.75e-05	0.000568	CcSEcCtD
Etodolac—Hyperhidrosis—Methotrexate—multiple sclerosis	5.72e-05	0.000565	CcSEcCtD
Etodolac—PTGS1—Selenium Micronutrient Network—CCL2—multiple sclerosis	5.72e-05	0.00154	CbGpPWpGaD
Etodolac—ALB—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	5.72e-05	0.00154	CbGpPWpGaD
Etodolac—Vomiting—Triamcinolone—multiple sclerosis	5.7e-05	0.000563	CcSEcCtD
Etodolac—Vomiting—Methylprednisolone—multiple sclerosis	5.69e-05	0.000562	CcSEcCtD
Etodolac—ALB—Vitamin B12 Metabolism—CCL2—multiple sclerosis	5.68e-05	0.00153	CbGpPWpGaD
Etodolac—Rash—Triamcinolone—multiple sclerosis	5.65e-05	0.000558	CcSEcCtD
Etodolac—Dermatitis—Triamcinolone—multiple sclerosis	5.65e-05	0.000558	CcSEcCtD
Etodolac—Anorexia—Methotrexate—multiple sclerosis	5.64e-05	0.000557	CcSEcCtD
Etodolac—Rash—Methylprednisolone—multiple sclerosis	5.64e-05	0.000557	CcSEcCtD
Etodolac—Dermatitis—Methylprednisolone—multiple sclerosis	5.63e-05	0.000556	CcSEcCtD
Etodolac—Urticaria—Prednisone—multiple sclerosis	5.63e-05	0.000556	CcSEcCtD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	5.61e-05	0.00151	CbGpPWpGaD
Etodolac—Headache—Triamcinolone—multiple sclerosis	5.61e-05	0.000555	CcSEcCtD
Etodolac—Headache—Methylprednisolone—multiple sclerosis	5.6e-05	0.000553	CcSEcCtD
Etodolac—Body temperature increased—Prednisone—multiple sclerosis	5.6e-05	0.000553	CcSEcCtD
Etodolac—Abdominal pain—Prednisone—multiple sclerosis	5.6e-05	0.000553	CcSEcCtD
Etodolac—SLC22A6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.59e-05	0.0015	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—SRM—multiple sclerosis	5.57e-05	0.0015	CbGpPWpGaD
Etodolac—Diarrhoea—Dexamethasone—multiple sclerosis	5.56e-05	0.00055	CcSEcCtD
Etodolac—Diarrhoea—Betamethasone—multiple sclerosis	5.56e-05	0.00055	CcSEcCtD
Etodolac—Hypotension—Methotrexate—multiple sclerosis	5.53e-05	0.000546	CcSEcCtD
Etodolac—PTGS2—Spinal Cord Injury—BDNF—multiple sclerosis	5.44e-05	0.00146	CbGpPWpGaD
Etodolac—ALB—Hemostasis—MERTK—multiple sclerosis	5.43e-05	0.00146	CbGpPWpGaD
Etodolac—ALB—Hemostasis—CD58—multiple sclerosis	5.43e-05	0.00146	CbGpPWpGaD
Etodolac—ALB—Hemostasis—SELPLG—multiple sclerosis	5.43e-05	0.00146	CbGpPWpGaD
Etodolac—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	5.39e-05	0.000533	CcSEcCtD
Etodolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—multiple sclerosis	5.39e-05	0.00145	CbGpPWpGaD
Etodolac—Dizziness—Dexamethasone—multiple sclerosis	5.38e-05	0.000531	CcSEcCtD
Etodolac—Dizziness—Betamethasone—multiple sclerosis	5.38e-05	0.000531	CcSEcCtD
Etodolac—Insomnia—Methotrexate—multiple sclerosis	5.35e-05	0.000529	CcSEcCtD
Etodolac—PTGS1—Selenium Micronutrient Network—ALB—multiple sclerosis	5.33e-05	0.00143	CbGpPWpGaD
Etodolac—Nausea—Triamcinolone—multiple sclerosis	5.32e-05	0.000526	CcSEcCtD
Etodolac—Paraesthesia—Methotrexate—multiple sclerosis	5.31e-05	0.000525	CcSEcCtD
Etodolac—Nausea—Methylprednisolone—multiple sclerosis	5.31e-05	0.000525	CcSEcCtD
Etodolac—RXRA—Developmental Biology—PRNP—multiple sclerosis	5.28e-05	0.00142	CbGpPWpGaD
Etodolac—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—multiple sclerosis	5.28e-05	0.00142	CbGpPWpGaD
Etodolac—Dyspnoea—Methotrexate—multiple sclerosis	5.28e-05	0.000521	CcSEcCtD
Etodolac—Somnolence—Methotrexate—multiple sclerosis	5.26e-05	0.00052	CcSEcCtD
Etodolac—Hypersensitivity—Prednisone—multiple sclerosis	5.22e-05	0.000515	CcSEcCtD
Etodolac—Dyspepsia—Methotrexate—multiple sclerosis	5.21e-05	0.000515	CcSEcCtD
Etodolac—RXRA—Metabolism—SRM—multiple sclerosis	5.19e-05	0.0014	CbGpPWpGaD
Etodolac—Vomiting—Dexamethasone—multiple sclerosis	5.17e-05	0.000511	CcSEcCtD
Etodolac—Vomiting—Betamethasone—multiple sclerosis	5.17e-05	0.000511	CcSEcCtD
Etodolac—ALB—Folate Metabolism—ICAM1—multiple sclerosis	5.17e-05	0.00139	CbGpPWpGaD
Etodolac—UGT2B7—Biological oxidations—POMC—multiple sclerosis	5.16e-05	0.00139	CbGpPWpGaD
Etodolac—Decreased appetite—Methotrexate—multiple sclerosis	5.14e-05	0.000508	CcSEcCtD
Etodolac—Rash—Betamethasone—multiple sclerosis	5.13e-05	0.000506	CcSEcCtD
Etodolac—Rash—Dexamethasone—multiple sclerosis	5.13e-05	0.000506	CcSEcCtD
Etodolac—Dermatitis—Dexamethasone—multiple sclerosis	5.12e-05	0.000506	CcSEcCtD
Etodolac—Dermatitis—Betamethasone—multiple sclerosis	5.12e-05	0.000506	CcSEcCtD
Etodolac—Fatigue—Methotrexate—multiple sclerosis	5.1e-05	0.000504	CcSEcCtD
Etodolac—Headache—Betamethasone—multiple sclerosis	5.09e-05	0.000503	CcSEcCtD
Etodolac—Headache—Dexamethasone—multiple sclerosis	5.09e-05	0.000503	CcSEcCtD
Etodolac—Asthenia—Prednisone—multiple sclerosis	5.08e-05	0.000502	CcSEcCtD
Etodolac—PTGS2—Selenium Micronutrient Network—ICAM1—multiple sclerosis	5.07e-05	0.00137	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—U2AF2—multiple sclerosis	5.06e-05	0.00136	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—HNRNPA1—multiple sclerosis	5.06e-05	0.00136	CbGpPWpGaD
Etodolac—Pain—Methotrexate—multiple sclerosis	5.06e-05	0.0005	CcSEcCtD
Etodolac—PTGS2—Spinal Cord Injury—IL4—multiple sclerosis	5.05e-05	0.00136	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.04e-05	0.00136	CbGpPWpGaD
Etodolac—Pruritus—Prednisone—multiple sclerosis	5.01e-05	0.000495	CcSEcCtD
Etodolac—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—multiple sclerosis	4.93e-05	0.00133	CbGpPWpGaD
Etodolac—Feeling abnormal—Methotrexate—multiple sclerosis	4.88e-05	0.000482	CcSEcCtD
Etodolac—PTGS1—Selenium Micronutrient Network—IFNG—multiple sclerosis	4.86e-05	0.00131	CbGpPWpGaD
Etodolac—Diarrhoea—Prednisone—multiple sclerosis	4.85e-05	0.000479	CcSEcCtD
Etodolac—Gastrointestinal pain—Methotrexate—multiple sclerosis	4.84e-05	0.000478	CcSEcCtD
Etodolac—ALB—Vitamin B12 Metabolism—IFNG—multiple sclerosis	4.83e-05	0.0013	CbGpPWpGaD
Etodolac—Nausea—Betamethasone—multiple sclerosis	4.83e-05	0.000477	CcSEcCtD
Etodolac—Nausea—Dexamethasone—multiple sclerosis	4.83e-05	0.000477	CcSEcCtD
Etodolac—RXRA—Biological oxidations—POMC—multiple sclerosis	4.81e-05	0.0013	CbGpPWpGaD
Etodolac—Urticaria—Methotrexate—multiple sclerosis	4.7e-05	0.000464	CcSEcCtD
Etodolac—Dizziness—Prednisone—multiple sclerosis	4.68e-05	0.000463	CcSEcCtD
Etodolac—Body temperature increased—Methotrexate—multiple sclerosis	4.68e-05	0.000462	CcSEcCtD
Etodolac—Abdominal pain—Methotrexate—multiple sclerosis	4.68e-05	0.000462	CcSEcCtD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.63e-05	0.00125	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.63e-05	0.00125	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—CCL2—multiple sclerosis	4.62e-05	0.00124	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—CYP27B1—multiple sclerosis	4.61e-05	0.00124	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—CYP24A1—multiple sclerosis	4.61e-05	0.00124	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	4.61e-05	0.00124	CbGpPWpGaD
Etodolac—RXRA—Generic Transcription Pathway—PGR—multiple sclerosis	4.58e-05	0.00123	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—CCL2—multiple sclerosis	4.54e-05	0.00122	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—SRM—multiple sclerosis	4.53e-05	0.00122	CbGpPWpGaD
Etodolac—PTGS2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	4.51e-05	0.00121	CbGpPWpGaD
Etodolac—Vomiting—Prednisone—multiple sclerosis	4.5e-05	0.000445	CcSEcCtD
Etodolac—Rash—Prednisone—multiple sclerosis	4.46e-05	0.000441	CcSEcCtD
Etodolac—Dermatitis—Prednisone—multiple sclerosis	4.46e-05	0.000441	CcSEcCtD
Etodolac—RXRA—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.45e-05	0.0012	CbGpPWpGaD
Etodolac—Headache—Prednisone—multiple sclerosis	4.44e-05	0.000438	CcSEcCtD
Etodolac—SLC22A6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.42e-05	0.00119	CbGpPWpGaD
Etodolac—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	4.41e-05	0.00119	CbGpPWpGaD
Etodolac—Hypersensitivity—Methotrexate—multiple sclerosis	4.36e-05	0.000431	CcSEcCtD
Etodolac—PTGS1—Selenium Micronutrient Network—IL1B—multiple sclerosis	4.34e-05	0.00117	CbGpPWpGaD
Etodolac—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	4.31e-05	0.00116	CbGpPWpGaD
Etodolac—Asthenia—Methotrexate—multiple sclerosis	4.25e-05	0.000419	CcSEcCtD
Etodolac—PTGS2—Selenium Micronutrient Network—ALB—multiple sclerosis	4.23e-05	0.00114	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—GPC5—multiple sclerosis	4.22e-05	0.00114	CbGpPWpGaD
Etodolac—Nausea—Prednisone—multiple sclerosis	4.21e-05	0.000416	CcSEcCtD
Etodolac—PTGS2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	4.2e-05	0.00113	CbGpPWpGaD
Etodolac—UGT1A9—Biological oxidations—POMC—multiple sclerosis	4.19e-05	0.00113	CbGpPWpGaD
Etodolac—Pruritus—Methotrexate—multiple sclerosis	4.19e-05	0.000414	CcSEcCtD
Etodolac—PTGS2—Spinal Cord Injury—TLR4—multiple sclerosis	4.18e-05	0.00113	CbGpPWpGaD
Etodolac—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.17e-05	0.00112	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—PTPRC—multiple sclerosis	4.11e-05	0.00111	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	4.1e-05	0.0011	CbGpPWpGaD
Etodolac—Diarrhoea—Methotrexate—multiple sclerosis	4.05e-05	0.0004	CcSEcCtD
Etodolac—PTGS2—Spinal Cord Injury—ICAM1—multiple sclerosis	4.01e-05	0.00108	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—ZFP36L1—multiple sclerosis	4e-05	0.00108	CbGpPWpGaD
Etodolac—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	4e-05	0.00108	CbGpPWpGaD
Etodolac—UGT1A3—NRF2 pathway—TGFB1—multiple sclerosis	3.99e-05	0.00107	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—IFNG—multiple sclerosis	3.93e-05	0.00106	CbGpPWpGaD
Etodolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—multiple sclerosis	3.93e-05	0.00106	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—CYP27B1—multiple sclerosis	3.92e-05	0.00106	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—CYP24A1—multiple sclerosis	3.92e-05	0.00106	CbGpPWpGaD
Etodolac—Dizziness—Methotrexate—multiple sclerosis	3.91e-05	0.000387	CcSEcCtD
Etodolac—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.91e-05	0.00105	CbGpPWpGaD
Etodolac—PTGS2—C-MYB transcription factor network—CD4—multiple sclerosis	3.87e-05	0.00104	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—IFNG—multiple sclerosis	3.86e-05	0.00104	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	3.83e-05	0.00103	CbGpPWpGaD
Etodolac—Vomiting—Methotrexate—multiple sclerosis	3.76e-05	0.000372	CcSEcCtD
Etodolac—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.75e-05	0.00101	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.75e-05	0.00101	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—STAT3—multiple sclerosis	3.75e-05	0.00101	CbGpPWpGaD
Etodolac—Rash—Methotrexate—multiple sclerosis	3.73e-05	0.000369	CcSEcCtD
Etodolac—Dermatitis—Methotrexate—multiple sclerosis	3.73e-05	0.000368	CcSEcCtD
Etodolac—Headache—Methotrexate—multiple sclerosis	3.71e-05	0.000366	CcSEcCtD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	3.7e-05	0.000996	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—SRM—multiple sclerosis	3.69e-05	0.000993	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	3.67e-05	0.000989	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CYP27B1—multiple sclerosis	3.66e-05	0.000985	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CYP24A1—multiple sclerosis	3.66e-05	0.000985	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—CCL2—multiple sclerosis	3.59e-05	0.000966	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—GPC5—multiple sclerosis	3.59e-05	0.000966	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.58e-05	0.000963	CbGpPWpGaD
Etodolac—Nausea—Methotrexate—multiple sclerosis	3.52e-05	0.000347	CcSEcCtD
Etodolac—ALB—Folate Metabolism—IL1B—multiple sclerosis	3.51e-05	0.000944	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—RRM1—multiple sclerosis	3.5e-05	0.000941	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—IL2—multiple sclerosis	3.49e-05	0.00094	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—TGFB1—multiple sclerosis	3.47e-05	0.000935	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—IL1B—multiple sclerosis	3.44e-05	0.000927	CbGpPWpGaD
Etodolac—PTGS1—Biological oxidations—POMC—multiple sclerosis	3.42e-05	0.00092	CbGpPWpGaD
Etodolac—UGT2B7—NRF2 pathway—TGFB1—multiple sclerosis	3.39e-05	0.000913	CbGpPWpGaD
Etodolac—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.38e-05	0.000911	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PLEK—multiple sclerosis	3.36e-05	0.000904	CbGpPWpGaD
Etodolac—RXRA—Metabolism—GPC5—multiple sclerosis	3.35e-05	0.000901	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—TNF—multiple sclerosis	3.24e-05	0.000873	CbGpPWpGaD
Etodolac—RXRA—Generic Transcription Pathway—VDR—multiple sclerosis	3.2e-05	0.000861	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CYP27B1—multiple sclerosis	3.19e-05	0.000858	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CYP24A1—multiple sclerosis	3.19e-05	0.000858	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	3.17e-05	0.000852	CbGpPWpGaD
Etodolac—RXRA—NRF2 pathway—TGFB1—multiple sclerosis	3.16e-05	0.000852	CbGpPWpGaD
Etodolac—PTGS1—Selenium Micronutrient Network—TNF—multiple sclerosis	3.15e-05	0.000847	CbGpPWpGaD
Etodolac—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	3.13e-05	0.000842	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	3.12e-05	0.000841	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.12e-05	0.000839	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—PABPC1—multiple sclerosis	3.1e-05	0.000835	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.07e-05	0.000826	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.07e-05	0.000826	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—IFNG—multiple sclerosis	3.05e-05	0.000822	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—RRM1—multiple sclerosis	2.97e-05	0.000801	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—SRM—multiple sclerosis	2.93e-05	0.000788	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—GPC5—multiple sclerosis	2.92e-05	0.000785	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.91e-05	0.000782	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—RPL5—multiple sclerosis	2.8e-05	0.000754	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	2.79e-05	0.00075	CbGpPWpGaD
Etodolac—PTGS2—C-MYB transcription factor network—MYC—multiple sclerosis	2.78e-05	0.000749	CbGpPWpGaD
Etodolac—RXRA—Metabolism—RRM1—multiple sclerosis	2.77e-05	0.000747	CbGpPWpGaD
Etodolac—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.77e-05	0.000745	CbGpPWpGaD
Etodolac—UGT1A9—NRF2 pathway—TGFB1—multiple sclerosis	2.76e-05	0.000742	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—IL1B—multiple sclerosis	2.72e-05	0.000733	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—IL2—multiple sclerosis	2.71e-05	0.00073	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—IL6—multiple sclerosis	2.62e-05	0.000705	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CYP27B1—multiple sclerosis	2.6e-05	0.0007	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CYP24A1—multiple sclerosis	2.6e-05	0.0007	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—MMP9—multiple sclerosis	2.57e-05	0.000691	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.56e-05	0.000689	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.55e-05	0.000687	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—TNF—multiple sclerosis	2.54e-05	0.000685	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.54e-05	0.000684	CbGpPWpGaD
Etodolac—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	2.54e-05	0.000684	CbGpPWpGaD
Etodolac—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	2.52e-05	0.000679	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.5e-05	0.000674	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—TNF—multiple sclerosis	2.5e-05	0.000673	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—RRM1—multiple sclerosis	2.42e-05	0.000651	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.38e-05	0.000642	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GPC5—multiple sclerosis	2.38e-05	0.00064	CbGpPWpGaD
Etodolac—ALB—Metabolism—SRM—multiple sclerosis	2.37e-05	0.000638	CbGpPWpGaD
Etodolac—ALB—Hemostasis—SELE—multiple sclerosis	2.36e-05	0.000637	CbGpPWpGaD
Etodolac—ALB—Platelet degranulation—TGFB1—multiple sclerosis	2.34e-05	0.000629	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.3e-05	0.000618	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	2.27e-05	0.00061	CbGpPWpGaD
Etodolac—PTGS2—Disease—GPC5—multiple sclerosis	2.25e-05	0.000607	CbGpPWpGaD
Etodolac—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	2.23e-05	0.000599	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—PGR—multiple sclerosis	2.2e-05	0.000593	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.15e-05	0.000579	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—MYC—multiple sclerosis	2.12e-05	0.000571	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—TGFB1—multiple sclerosis	2.12e-05	0.00057	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—MAPK1—multiple sclerosis	2.07e-05	0.000559	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CYP27B1—multiple sclerosis	2.06e-05	0.000555	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CYP24A1—multiple sclerosis	2.06e-05	0.000555	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—IL6—multiple sclerosis	2.05e-05	0.000553	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.03e-05	0.000547	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	2.02e-05	0.000544	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.02e-05	0.000543	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—IL6—multiple sclerosis	2.02e-05	0.000543	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—BCHE—multiple sclerosis	2.01e-05	0.000541	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—TNF—multiple sclerosis	1.98e-05	0.000532	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—RRM1—multiple sclerosis	1.97e-05	0.00053	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—SRM—multiple sclerosis	1.94e-05	0.000522	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GPC5—multiple sclerosis	1.89e-05	0.000508	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.87e-05	0.000505	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.85e-05	0.000498	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—TYK2—multiple sclerosis	1.84e-05	0.000495	CbGpPWpGaD
Etodolac—CYP2C9—Biological oxidations—POMC—multiple sclerosis	1.8e-05	0.000484	CbGpPWpGaD
Etodolac—ALB—Hemostasis—ITGA4—multiple sclerosis	1.71e-05	0.00046	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—BCHE—multiple sclerosis	1.71e-05	0.00046	CbGpPWpGaD
Etodolac—ALB—Hemostasis—IFNB1—multiple sclerosis	1.7e-05	0.000457	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.69e-05	0.000454	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP27B1—multiple sclerosis	1.67e-05	0.000449	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP24A1—multiple sclerosis	1.67e-05	0.000449	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.63e-05	0.000439	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	1.63e-05	0.000439	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.61e-05	0.000434	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.6e-05	0.000431	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—IL6—multiple sclerosis	1.59e-05	0.000429	CbGpPWpGaD
Etodolac—RXRA—Metabolism—BCHE—multiple sclerosis	1.59e-05	0.000429	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—RRM1—multiple sclerosis	1.56e-05	0.000421	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—VDR—multiple sclerosis	1.54e-05	0.000415	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.53e-05	0.000411	CbGpPWpGaD
Etodolac—ALB—Metabolism—GPC5—multiple sclerosis	1.53e-05	0.000411	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.47e-05	0.000395	CbGpPWpGaD
Etodolac—PTGS2—Disease—RPL5—multiple sclerosis	1.47e-05	0.000394	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—MMP9—multiple sclerosis	1.45e-05	0.00039	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.44e-05	0.000388	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.44e-05	0.000387	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.41e-05	0.00038	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.41e-05	0.000379	CbGpPWpGaD
Etodolac—PTGS2—Disease—SLC11A1—multiple sclerosis	1.4e-05	0.000378	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—BCHE—multiple sclerosis	1.39e-05	0.000374	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.37e-05	0.000368	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.37e-05	0.000368	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.34e-05	0.000362	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.34e-05	0.00036	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	1.33e-05	0.000358	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.31e-05	0.000353	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—STAT3—multiple sclerosis	1.29e-05	0.000347	CbGpPWpGaD
Etodolac—RXRA—Generic Transcription Pathway—MYC—multiple sclerosis	1.27e-05	0.000342	CbGpPWpGaD
Etodolac—ALB—Metabolism—RRM1—multiple sclerosis	1.27e-05	0.000341	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.25e-05	0.000336	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.21e-05	0.000327	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—APOE—multiple sclerosis	1.21e-05	0.000325	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.2e-05	0.000322	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—TGFB1—multiple sclerosis	1.19e-05	0.000321	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—MAPK1—multiple sclerosis	1.17e-05	0.000315	CbGpPWpGaD
Etodolac—ALB—Hemostasis—IL2RA—multiple sclerosis	1.17e-05	0.000314	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—BCHE—multiple sclerosis	1.13e-05	0.000305	CbGpPWpGaD
Etodolac—PTGS2—Disease—CD28—multiple sclerosis	1.12e-05	0.000302	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—TNF—multiple sclerosis	1.11e-05	0.0003	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.04e-05	0.000281	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—POMC—multiple sclerosis	1.04e-05	0.000279	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	1.04e-05	0.000279	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.04e-05	0.000279	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—APOE—multiple sclerosis	1.03e-05	0.000277	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	1.02e-05	0.000274	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	9.81e-06	0.000264	CbGpPWpGaD
Etodolac—RXRA—Metabolism—APOE—multiple sclerosis	9.58e-06	0.000258	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	9.5e-06	0.000256	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—ALB—multiple sclerosis	9.46e-06	0.000255	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—IL6—multiple sclerosis	8.99e-06	0.000242	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—BCHE—multiple sclerosis	8.98e-06	0.000242	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—POMC—multiple sclerosis	8.83e-06	0.000238	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.43e-06	0.000227	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—APOE—multiple sclerosis	8.35e-06	0.000225	CbGpPWpGaD
Etodolac—RXRA—Metabolism—POMC—multiple sclerosis	8.23e-06	0.000222	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—ALB—multiple sclerosis	8.05e-06	0.000217	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.03e-06	0.000216	CbGpPWpGaD
Etodolac—PTGS2—Disease—CD86—multiple sclerosis	8e-06	0.000215	CbGpPWpGaD
Etodolac—RXRA—Metabolism—ALB—multiple sclerosis	7.51e-06	0.000202	CbGpPWpGaD
Etodolac—ALB—Metabolism—BCHE—multiple sclerosis	7.27e-06	0.000196	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—POMC—multiple sclerosis	7.17e-06	0.000193	CbGpPWpGaD
Etodolac—PTGS2—Disease—CCR5—multiple sclerosis	7.09e-06	0.000191	CbGpPWpGaD
Etodolac—PTGS2—Disease—HLA-A—multiple sclerosis	6.91e-06	0.000186	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.9e-06	0.000186	CbGpPWpGaD
Etodolac—ALB—Hemostasis—IL2—multiple sclerosis	6.85e-06	0.000184	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—APOE—multiple sclerosis	6.81e-06	0.000183	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—ALB—multiple sclerosis	6.54e-06	0.000176	CbGpPWpGaD
Etodolac—PTGS2—Disease—APOE—multiple sclerosis	6.45e-06	0.000174	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.29e-06	0.000169	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—MYC—multiple sclerosis	6.12e-06	0.000165	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—BCHE—multiple sclerosis	5.95e-06	0.00016	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—POMC—multiple sclerosis	5.85e-06	0.000157	CbGpPWpGaD
Etodolac—PTGS2—Disease—CD80—multiple sclerosis	5.83e-06	0.000157	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—APOE—multiple sclerosis	5.4e-06	0.000145	CbGpPWpGaD
Etodolac—ALB—Hemostasis—TGFB1—multiple sclerosis	5.34e-06	0.000144	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—ALB—multiple sclerosis	5.33e-06	0.000144	CbGpPWpGaD
Etodolac—ALB—Hemostasis—MAPK1—multiple sclerosis	5.24e-06	0.000141	CbGpPWpGaD
Etodolac—PTGS2—Disease—TYK2—multiple sclerosis	4.92e-06	0.000133	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—POMC—multiple sclerosis	4.64e-06	0.000125	CbGpPWpGaD
Etodolac—PTGS2—Disease—CD4—multiple sclerosis	4.45e-06	0.00012	CbGpPWpGaD
Etodolac—ALB—Metabolism—APOE—multiple sclerosis	4.37e-06	0.000118	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ALB—multiple sclerosis	4.23e-06	0.000114	CbGpPWpGaD
Etodolac—ALB—Metabolism—POMC—multiple sclerosis	3.75e-06	0.000101	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—APOE—multiple sclerosis	3.58e-06	9.63e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—STAT3—multiple sclerosis	3.45e-06	9.28e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MYC—multiple sclerosis	3.2e-06	8.62e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—TGFB1—multiple sclerosis	3.2e-06	8.6e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MAPK1—multiple sclerosis	3.13e-06	8.44e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—POMC—multiple sclerosis	3.07e-06	8.27e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ALB—multiple sclerosis	2.8e-06	7.54e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—IL6—multiple sclerosis	2.41e-06	6.48e-05	CbGpPWpGaD
